Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ASNDARGX

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ASND

73/100

ARGX

80/100

Quality

Is it a profitable, well-run business?

ASND

6.5/10

ARGX

8.2/10

Growth

Is the company growing?

ASND

9.7/10

ARGX

10.0/10

Valuation

Is the price reasonable? (higher = cheaper)

ASND

4.6/10

ARGX

4.1/10

Risk

How risky are the shares? (higher = lower risk)

ASND

8.1/10

ARGX

7.7/10

Momentum

Is the share price trending up?

ASND

9.4/10

ARGX

7.5/10

Financial strength

Is the balance sheet healthy?

ASND

7.1/10

ARGX

9.0/10

The balanced view

Model-generated

Ascendis Pharma A/S

This company scores above average, with solid growth and a positive price trend.

Leads on: valuation, risk, momentum

Best feature: solid growth (Revenue growth (FY): 90.2%)

Watch out: weakest area: valuation (EV / EBITDA: 168.8x)

argenx SE

This company scores well across most areas, with solid growth and supportive analyst views, although its current valuation deserves attention.

Leads on: quality, growth, financial strength

Best feature: solid growth (Revenue growth (FY): 89.6%)

Watch out: valuation may be demanding (DCF upside: -668.4%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.